NutraGene offers commercial genetic Type II diabetes test in India
People in India now have access to NutraGene's Type II diabetes genetic test, which aims to provide physicians an effective tool in assessing the risk of diabetes in the country and to help implement personalised prevention and management strategies.
India faces a potential diabetes epidemic with the number of diabetics expected to increase from 61.3 million in 2011 to 101 million by 2030. Pre-diabetes, a state when an individual's blood glucose levels are higher than normal but not high enough to be Type II diabetes, is also widespread in India. Studies estimate that nearly 14 to 22 per cent of the Indian population falls in the pre-diabetic condition, suggesting that pre-diabetes is more prominent in the Indian population than Type II diabetes.